These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15659760)

  • 1. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.
    Chu JJH; Rajamanonmani R; Li J; Bhuvanakantham R; Lescar J; Ng ML
    J Gen Virol; 2005 Feb; 86(Pt 2):405-412. PubMed ID: 15659760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.
    Chu JH; Chiang CC; Ng ML
    J Immunol; 2007 Mar; 178(5):2699-705. PubMed ID: 17312111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide inhibitors of dengue virus and West Nile virus infectivity.
    Hrobowski YM; Garry RF; Michael SF
    Virol J; 2005 Jun; 2():49. PubMed ID: 15927084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.
    McAuley AJ; Torres M; Plante JA; Huang CY; Bente DA; Beasley DWC
    J Virol; 2016 May; 90(9):4757-4770. PubMed ID: 26912625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of West Nile virus neutralization by a therapeutic antibody.
    Nybakken GE; Oliphant T; Johnson S; Burke S; Diamond MS; Fremont DH
    Nature; 2005 Sep; 437(7059):764-9. PubMed ID: 16193056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses.
    Liu SA; Haque M; Stanfield B; Andrews FM; Roy AA; Kousoulas KG
    Vet Microbiol; 2017 Jan; 198():51-58. PubMed ID: 28062007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. West Nile virus is neutralized by HOCl-modified human serum albumin that binds to domain III of the viral envelope protein E.
    Vossmann M; Kirst M; Ludolfs D; Schreiber M
    Virology; 2008 Apr; 373(2):322-8. PubMed ID: 18191981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells.
    Hershkovitz O; Rosental B; Rosenberg LA; Navarro-Sanchez ME; Jivov S; Zilka A; Gershoni-Yahalom O; Brient-Litzler E; Bedouelle H; Ho JW; Campbell KS; Rager-Zisman B; Despres P; Porgador A
    J Immunol; 2009 Aug; 183(4):2610-21. PubMed ID: 19635919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Japanese encephalitis virus infection by flavivirus recombinant E protein domain III.
    Fan J; Liu Y; Xie X; Zhang B; Yuan Z
    Virol Sin; 2013 Jun; 28(3):152-60. PubMed ID: 23709058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies.
    Chua AJ; Vituret C; Tan ML; Gonzalez G; Boulanger P; Ng ML; Hong SS
    Virol J; 2013 Apr; 10():129. PubMed ID: 23617954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid purification of recombinant dengue and West Nile virus envelope Domain III proteins by metal affinity membrane chromatography.
    Tan LC; Chua AJ; Goh LS; Pua SM; Cheong YK; Ng ML
    Protein Expr Purif; 2010 Nov; 74(1):129-37. PubMed ID: 20600950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery.
    Tinker JK; Yan J; Knippel RJ; Panayiotou P; Cornell KA
    Toxins (Basel); 2014 Apr; 6(4):1397-418. PubMed ID: 24759174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.
    Spohn G; Jennings GT; Martina BE; Keller I; Beck M; Pumpens P; Osterhaus AD; Bachmann MF
    Virol J; 2010 Jul; 7():146. PubMed ID: 20604940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells.
    Chu JJ; Ng ML
    J Biol Chem; 2004 Dec; 279(52):54533-41. PubMed ID: 15475343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry.
    Chin JF; Chu JJ; Ng ML
    Microbes Infect; 2007 Jan; 9(1):1-6. PubMed ID: 17196419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice.
    Dunn MD; Rossi SL; Carter DM; Vogt MR; Mehlhop E; Diamond MS; Ross TM
    Virol J; 2010 May; 7():95. PubMed ID: 20462412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III.
    Zhang S; Bovshik EI; Maillard R; Gromowski GD; Volk DE; Schein CH; Huang CY; Gorenstein DG; Lee JC; Barrett AD; Beasley DW
    Virology; 2010 Jul; 403(1):85-91. PubMed ID: 20447672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.
    Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S
    Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Diagnosis of Flavivirus Infections in Horses Using Viral Envelope Protein Domain III Antigens in Enzyme-Linked Immunosorbent Assay.
    Piyasena TBH; Setoh YX; Hobson-Peters J; Prow NA; Bielefeldt-Ohmann H; Khromykh AA; Perera D; Cardosa MJ; Kirkland PD; Hall RA
    Vector Borne Zoonotic Dis; 2017 Dec; 17(12):825-835. PubMed ID: 29083957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.